CVS Group's (CVSG) "Buy" Rating Reaffirmed at Berenberg Bank

Key Points

• Berenberg Bank reaffirmed its “Buy” rating on CVS Group and set a GBX 2,000 price target, implying 63.13% potential upside from the current price.
• Analyst sentiment remains positive, with four Buy ratings and two Holds, producing a consensus “Moderate Buy” rating and average target price of GBX 1,666.67.
• CVS Group shares fell 5.8% to open at GBX 1,226, while company insiders have recently purchased shares worth approximately £4.96 million over the past three months.

CVS Group (LON:CVSG - Get Free Report)'s stock had its "buy" rating reissued by stock analysts at Berenberg Bank in a note issued to investors on Thursday, London Stock Exchange reports. They presently have a GBX 2,000 price objective on the stock. Berenberg Bank's target price points to a potential upside of 63.13% from the company's current price.

Several other equities analysts also recently issued reports on the stock. Jefferies Financial Group boosted their price target on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the company a "hold" rating in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, CVS Group has a consensus rating of "Moderate Buy" and an average target price of GBX 1,666.67.

CVS Group Trading Down 5.8%

Shares of LON CVSG opened at GBX 1,226 on Thursday. The company has a market cap of £833.31 million, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. CVS Group has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. The stock's 50 day simple moving average is GBX 1,289.88 and its 200 day simple moving average is GBX 1,230.

CVS Group (LON:CVSG - Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a return on equity of 5.35% and a net margin of 2.31%. Equities research analysts expect that CVS Group will post 93.9393939 EPS for the current year.

Insider Transactions at CVS Group

In other CVS Group news, insider David Wilton acquired 1,500 shares of the firm's stock in a transaction that occurred on Tuesday, August 4th. The stock was acquired at an average cost of GBX 1,276 per share, with a total value of £19,140. Also, insider Robin Alfonso bought 768 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was acquired at an average price of GBX 1,294 per share, for a total transaction of £9,937.92. Over the last three months, insiders acquired 3,860 shares of company stock worth $4,956,696. Company insiders own 1.48% of the company's stock.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.